SUNDRUG CO.,LTD. · 株式会社サンドラッグ
Ownership & governance
Executives 3Directors 7Avg age 61Avg tenure 12.6y
HS
Hiroshi Sadakata
Chief Executive Officer
Age 55Since 2022-03-31
+9
Executives3
HS
Hiroshi Sadakata
Chief Executive Officer
Age 55Since 2022-03-31
YK
Yoshinobu Kato
Chief Administrative Officer
——
YS
Yoshimitsu Sakai
Corporate Officer/Principal
Age 61Since 2001-03-31
Board of directors7
NT
Naoki Tada
Director/Board Member
Age 63Since 2001-05-31
TT
Takashi Tada
Director/Board Member
Age 57Since 2017-05-31
HS
Hiroshi Sadakata
Director/Board Member
Age 55Since 2008-05-31
YS
Yoshimitsu Sakai
Director/Board Member
Age 61Since 2010-05-31
MM
Masato Matsumoto
Director/Board Member
Age 69Since 2018-05-31
TT
Tomoko Tsuji
Director/Board Member
Age 69Since 2020-05-31
RS
Ritsuko Saito
Director/Board Member
Age 61Since 2024-05-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Naoki Tada | 39.29 % | 46,889,000 |
| Orbis Investment Management Ltd. | 4.939 % | 5,893,615 |
| Orbis Portfolio Management (Europe) LLP | 3.367 % | 4,017,795 |
| SUNDRUG CO.,LTD. | 1.968 % | 2,348,200 |
| Takashi Tada | 1.849 % | 2,207,000 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 4,674.29Range 3,820–5,600Analysts 7
3,820Mean 4,674.295,600
- Strong buy 2
- Buy 2
- Hold 3
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.